The efficacy of tranexamic acid which is a drug that promotes clotting of blood, in preventing blood loss in patients undergoing surgeries in and around hip joint
Phase 3
- Conditions
- Health Condition 1: V00-Y99- External causes of morbidity
- Registration Number
- CTRI/2021/09/036855
- Lead Sponsor
- Pt BD Sharma PGIMS Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients requiring major periarticular hip surgeries
Exclusion Criteria
1.Psychiatric patients
2.Any abnormal bleeding disorder like hemophilias, deranged international normalized ratio
3.Any previous history of adverse reaction or allergy to tranexamic acid
4.Congenital or acquired coagulopathy
5.Recent history of thrombo-embolic episode
6.Fracture neck of femur requiring closed reduction internal fixation with cannulated cancellous screws
7.Implant removal procedure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method